Report Detail

Request for Sample of this report

Pharma & Healthcare Global PSA Test Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4682968
    • |
  • 06 March, 2026
    • |
  • Global
    • |
  • 136 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global PSA Test market size was valued at US$ 653 million in 2025 and is forecast to a readjusted size of US$ 1086 million by 2032 with a CAGR of 7.6% during review period.
The PSA test is an in vitro diagnostic blood test that measures prostate-specific antigen and related forms (e.g., total PSA, free PSA, and derived ratios) to support risk assessment and clinical decision-making for prostate conditions. PSA is a protein produced by prostate tissue, and its level can be influenced by multiple non-malignant factors; therefore, PSA testing is typically interpreted within a “screen–stratify–confirm” pathway together with digital rectal exam, imaging (such as prostate MRI), and, when indicated, tissue sampling. It is used for prostate cancer risk evaluation, post-treatment monitoring and recurrence surveillance, and also contributes to differential management of benign prostatic hyperplasia and prostatitis. Methodologically, PSA testing is predominantly immunoassay-based, spanning high-throughput automated laboratory platforms (e.g., chemiluminescent immunoassays) and selected rapid-testing formats. Its core value is earlier risk stratification and improved triage efficiency, while requiring standardized use and quality control to balance benefits against potential overdiagnosis and overtreatment risks. In 2025, global PSA test production reached approximately 79350 k unit and price is 8 USD/Unit.The average gross profit margin of this product is 55%.
Population aging and rising awareness of prostate health, combined with more structured screening and follow-up pathways, support steady demand across health check-ups, outpatient triage, and oncology monitoring. As guidelines emphasize shared decision-making and risk-stratified management, PSA use is evolving from a single numeric readout toward combined indicators and stratification strategies—favoring higher-throughput, traceable, and workflow-integrated laboratory testing. Because PSA is organ-specific rather than cancer-specific, false positives and false negatives can occur; without robust stratification and follow-up governance, unnecessary downstream procedures and treatment risks may increase, shaping payer and public acceptance of broad screening. In addition, inter-platform comparability, calibration and QC systems, and the capability to integrate pre-analytics and informatics all influence result consistency and clinical confidence, raising switching costs and procurement thresholds for providers. Demand is shifting from “PSA-only” toward refined risk stratification, emphasizing linkage with free/total PSA ratios, risk models, imaging grading, and pathology pathways to reduce unnecessary invasive steps while improving identification of higher-risk men. Across settings, check-up centers prioritize standardization and turnaround efficiency, while urology clinics and follow-up programs value longitudinal comparability, trend monitoring, and case-management capability—driving closed-loop workflows and traceable data across lab, clinic, imaging, and pathology. Upstream value is concentrated in immunoassay critical materials and consumables: high-specificity monoclonal antibodies and antigen materials, calibrator/control systems, chemiluminescent or enzyme labels, magnetic beads/microparticle carriers, and buffer/blocking formulations that determine sensitivity and batch consistency. Single-use plastics (reaction cups, sampling components, microfluidic cartridges) and compatible analyzer modules underpin scalable delivery. Material purity stability, batch-to-batch control and supply resilience—together with system-level matching to platform algorithms and calibration strategies—are decisive for long-term reliability and compliant commercialization.
This report is a detailed and comprehensive analysis for global PSA Test market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global PSA Test market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSA Test market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSA Test market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global PSA Test market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PSA Test
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global PSA Test market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Siemens Healthcare, DiaSorin, Roche, Danaher, PerkinElmer, Tosoh, QuidelOrtho, Fujirebio, Mediwatch, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
PSA Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CLIA
ELISA
Others
Market segment by Assay
Total PSA (tPSA)
Free PSA (fPSA)
Other
Market segment by End Users
Hospital
Independent Lab
Other
Market segment by Application
Screening
Post-treatment Monitoring
Others
Major players covered
Abbott
Siemens Healthcare
DiaSorin
Roche
Danaher
PerkinElmer
Tosoh
QuidelOrtho
Fujirebio
Mediwatch
BodiTech
SENBT
Antu Biotechnology
Snibe
Fuzhou Hanbaikang Biotechnology
Hantang Biotechnology
Aicon Biotechnology
Yahuilong Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PSA Test product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PSA Test, with price, sales quantity, revenue, and global market share of PSA Test from 2021 to 2026.
Chapter 3, the PSA Test competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PSA Test breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and PSA Test market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PSA Test.
Chapter 14 and 15, to describe PSA Test sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global PSA Test Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 CLIA
    • 1.3.3 ELISA
    • 1.3.4 Others
  • 1.4 Market Analysis by Assay
    • 1.4.1 Overview: Global PSA Test Consumption Value by Assay: 2021 Versus 2025 Versus 2032
    • 1.4.2 Total PSA (tPSA)
    • 1.4.3 Free PSA (fPSA)
    • 1.4.4 Other
  • 1.5 Market Analysis by End Users
    • 1.5.1 Overview: Global PSA Test Consumption Value by End Users: 2021 Versus 2025 Versus 2032
    • 1.5.2 Hospital
    • 1.5.3 Independent Lab
    • 1.5.4 Other
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global PSA Test Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Screening
    • 1.6.3 Post-treatment Monitoring
    • 1.6.4 Others
  • 1.7 Global PSA Test Market Size & Forecast
    • 1.7.1 Global PSA Test Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global PSA Test Sales Quantity (2021-2032)
    • 1.7.3 Global PSA Test Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott PSA Test Product and Services
    • 2.1.4 Abbott PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Siemens Healthcare
    • 2.2.1 Siemens Healthcare Details
    • 2.2.2 Siemens Healthcare Major Business
    • 2.2.3 Siemens Healthcare PSA Test Product and Services
    • 2.2.4 Siemens Healthcare PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Siemens Healthcare Recent Developments/Updates
  • 2.3 DiaSorin
    • 2.3.1 DiaSorin Details
    • 2.3.2 DiaSorin Major Business
    • 2.3.3 DiaSorin PSA Test Product and Services
    • 2.3.4 DiaSorin PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 DiaSorin Recent Developments/Updates
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche PSA Test Product and Services
    • 2.4.4 Roche PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Roche Recent Developments/Updates
  • 2.5 Danaher
    • 2.5.1 Danaher Details
    • 2.5.2 Danaher Major Business
    • 2.5.3 Danaher PSA Test Product and Services
    • 2.5.4 Danaher PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Danaher Recent Developments/Updates
  • 2.6 PerkinElmer
    • 2.6.1 PerkinElmer Details
    • 2.6.2 PerkinElmer Major Business
    • 2.6.3 PerkinElmer PSA Test Product and Services
    • 2.6.4 PerkinElmer PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 PerkinElmer Recent Developments/Updates
  • 2.7 Tosoh
    • 2.7.1 Tosoh Details
    • 2.7.2 Tosoh Major Business
    • 2.7.3 Tosoh PSA Test Product and Services
    • 2.7.4 Tosoh PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Tosoh Recent Developments/Updates
  • 2.8 QuidelOrtho
    • 2.8.1 QuidelOrtho Details
    • 2.8.2 QuidelOrtho Major Business
    • 2.8.3 QuidelOrtho PSA Test Product and Services
    • 2.8.4 QuidelOrtho PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 QuidelOrtho Recent Developments/Updates
  • 2.9 Fujirebio
    • 2.9.1 Fujirebio Details
    • 2.9.2 Fujirebio Major Business
    • 2.9.3 Fujirebio PSA Test Product and Services
    • 2.9.4 Fujirebio PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Fujirebio Recent Developments/Updates
  • 2.10 Mediwatch
    • 2.10.1 Mediwatch Details
    • 2.10.2 Mediwatch Major Business
    • 2.10.3 Mediwatch PSA Test Product and Services
    • 2.10.4 Mediwatch PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Mediwatch Recent Developments/Updates
  • 2.11 BodiTech
    • 2.11.1 BodiTech Details
    • 2.11.2 BodiTech Major Business
    • 2.11.3 BodiTech PSA Test Product and Services
    • 2.11.4 BodiTech PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 BodiTech Recent Developments/Updates
  • 2.12 SENBT
    • 2.12.1 SENBT Details
    • 2.12.2 SENBT Major Business
    • 2.12.3 SENBT PSA Test Product and Services
    • 2.12.4 SENBT PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 SENBT Recent Developments/Updates
  • 2.13 Antu Biotechnology
    • 2.13.1 Antu Biotechnology Details
    • 2.13.2 Antu Biotechnology Major Business
    • 2.13.3 Antu Biotechnology PSA Test Product and Services
    • 2.13.4 Antu Biotechnology PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Antu Biotechnology Recent Developments/Updates
  • 2.14 Snibe
    • 2.14.1 Snibe Details
    • 2.14.2 Snibe Major Business
    • 2.14.3 Snibe PSA Test Product and Services
    • 2.14.4 Snibe PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Snibe Recent Developments/Updates
  • 2.15 Fuzhou Hanbaikang Biotechnology
    • 2.15.1 Fuzhou Hanbaikang Biotechnology Details
    • 2.15.2 Fuzhou Hanbaikang Biotechnology Major Business
    • 2.15.3 Fuzhou Hanbaikang Biotechnology PSA Test Product and Services
    • 2.15.4 Fuzhou Hanbaikang Biotechnology PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Fuzhou Hanbaikang Biotechnology Recent Developments/Updates
  • 2.16 Hantang Biotechnology
    • 2.16.1 Hantang Biotechnology Details
    • 2.16.2 Hantang Biotechnology Major Business
    • 2.16.3 Hantang Biotechnology PSA Test Product and Services
    • 2.16.4 Hantang Biotechnology PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Hantang Biotechnology Recent Developments/Updates
  • 2.17 Aicon Biotechnology
    • 2.17.1 Aicon Biotechnology Details
    • 2.17.2 Aicon Biotechnology Major Business
    • 2.17.3 Aicon Biotechnology PSA Test Product and Services
    • 2.17.4 Aicon Biotechnology PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Aicon Biotechnology Recent Developments/Updates
  • 2.18 Yahuilong Biotechnology
    • 2.18.1 Yahuilong Biotechnology Details
    • 2.18.2 Yahuilong Biotechnology Major Business
    • 2.18.3 Yahuilong Biotechnology PSA Test Product and Services
    • 2.18.4 Yahuilong Biotechnology PSA Test Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Yahuilong Biotechnology Recent Developments/Updates

3 Competitive Environment: PSA Test by Manufacturer

  • 3.1 Global PSA Test Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global PSA Test Revenue by Manufacturer (2021-2026)
  • 3.3 Global PSA Test Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of PSA Test by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 PSA Test Manufacturer Market Share in 2025
    • 3.4.3 Top 6 PSA Test Manufacturer Market Share in 2025
  • 3.5 PSA Test Market: Overall Company Footprint Analysis
    • 3.5.1 PSA Test Market: Region Footprint
    • 3.5.2 PSA Test Market: Company Product Type Footprint
    • 3.5.3 PSA Test Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global PSA Test Market Size by Region
    • 4.1.1 Global PSA Test Sales Quantity by Region (2021-2032)
    • 4.1.2 Global PSA Test Consumption Value by Region (2021-2032)
    • 4.1.3 Global PSA Test Average Price by Region (2021-2032)
  • 4.2 North America PSA Test Consumption Value (2021-2032)
  • 4.3 Europe PSA Test Consumption Value (2021-2032)
  • 4.4 Asia-Pacific PSA Test Consumption Value (2021-2032)
  • 4.5 South America PSA Test Consumption Value (2021-2032)
  • 4.6 Middle East & Africa PSA Test Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global PSA Test Sales Quantity by Type (2021-2032)
  • 5.2 Global PSA Test Consumption Value by Type (2021-2032)
  • 5.3 Global PSA Test Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global PSA Test Sales Quantity by Application (2021-2032)
  • 6.2 Global PSA Test Consumption Value by Application (2021-2032)
  • 6.3 Global PSA Test Average Price by Application (2021-2032)

7 North America

  • 7.1 North America PSA Test Sales Quantity by Type (2021-2032)
  • 7.2 North America PSA Test Sales Quantity by Application (2021-2032)
  • 7.3 North America PSA Test Market Size by Country
    • 7.3.1 North America PSA Test Sales Quantity by Country (2021-2032)
    • 7.3.2 North America PSA Test Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe PSA Test Sales Quantity by Type (2021-2032)
  • 8.2 Europe PSA Test Sales Quantity by Application (2021-2032)
  • 8.3 Europe PSA Test Market Size by Country
    • 8.3.1 Europe PSA Test Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe PSA Test Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific PSA Test Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific PSA Test Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific PSA Test Market Size by Region
    • 9.3.1 Asia-Pacific PSA Test Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific PSA Test Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America PSA Test Sales Quantity by Type (2021-2032)
  • 10.2 South America PSA Test Sales Quantity by Application (2021-2032)
  • 10.3 South America PSA Test Market Size by Country
    • 10.3.1 South America PSA Test Sales Quantity by Country (2021-2032)
    • 10.3.2 South America PSA Test Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa PSA Test Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa PSA Test Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa PSA Test Market Size by Country
    • 11.3.1 Middle East & Africa PSA Test Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa PSA Test Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 PSA Test Market Drivers
  • 12.2 PSA Test Market Restraints
  • 12.3 PSA Test Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of PSA Test and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of PSA Test
  • 13.3 PSA Test Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 PSA Test Typical Distributors
  • 14.3 PSA Test Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on PSA Test. Industry analysis & Market Report on PSA Test is a syndicated market report, published as Global PSA Test Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of PSA Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo